| __timestamp | Supernus Pharmaceuticals, Inc. | argenx SE |
|---|---|---|
| Wednesday, January 1, 2014 | 19586000 | 15411924 |
| Thursday, January 1, 2015 | 29135000 | 22593274 |
| Friday, January 1, 2016 | 42791000 | 33173050 |
| Sunday, January 1, 2017 | 49577000 | 62224159 |
| Monday, January 1, 2018 | 89209000 | 95607434 |
| Tuesday, January 1, 2019 | 69099000 | 221269028 |
| Wednesday, January 1, 2020 | 75961000 | 400745069 |
| Friday, January 1, 2021 | 90467000 | 580520000 |
| Saturday, January 1, 2022 | 74552000 | 663366000 |
| Sunday, January 1, 2023 | 91593000 | 755113687 |
Unlocking the unknown
In the ever-evolving pharmaceutical landscape, innovation is the key to staying ahead. Over the past decade, Argenx SE and Supernus Pharmaceuticals, Inc. have demonstrated contrasting trajectories in their research and development (R&D) investments. Starting in 2014, Supernus Pharmaceuticals led with a modest R&D expenditure, but by 2023, Argenx SE had surged ahead, increasing its R&D spending by nearly 4,800% compared to its 2014 levels. This remarkable growth underscores Argenx SE's commitment to innovation, as it consistently outpaced Supernus Pharmaceuticals from 2019 onwards. By 2023, Argenx SE's R&D expenses were approximately eight times higher than those of Supernus Pharmaceuticals. This trend highlights the strategic focus of Argenx SE on pioneering advancements in the pharmaceutical industry, setting a benchmark for its peers.
Research and Development: Comparing Key Metrics for Novo Nordisk A/S and Supernus Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Takeda Pharmaceutical Company Limited and Supernus Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for argenx SE and Alnylam Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for argenx SE and Dr. Reddy's Laboratories Limited
argenx SE or Opthea Limited: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for argenx SE and ADMA Biologics, Inc.
Research and Development Investment: argenx SE vs Catalyst Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and Supernus Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Supernus Pharmaceuticals, Inc.
R&D Insights: How Corcept Therapeutics Incorporated and Supernus Pharmaceuticals, Inc. Allocate Funds
Analyzing R&D Budgets: Apellis Pharmaceuticals, Inc. vs Supernus Pharmaceuticals, Inc.
Analyzing R&D Budgets: Supernus Pharmaceuticals, Inc. vs Viridian Therapeutics, Inc.